IRCT201203129274N1Completed未知
The efficacy of botox in treating peyronie disease; a clinical trial
Research Deputy of Ahvaz University of Medical Science and Health science0 sites10 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- Male
Inclusion Criteria
- •Inclusion criterion: stable peyronie plaque. Exclusion criteria : active phase of peyronie disease; less than 1 year history of peyronie disease and allegy to botox
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
H-22411: BOTOX® for Peyronie's DiseasePeyronie's DiseaseNCT00812838Mohit Khera12
Active, not recruiting
Phase 1
Treatment with Botox in patients with urinary incontinence (accidental loss of urine) due to neurogenic detrusor overactivity (bladder problems resulting from disease or damage to the nervous systemrinary incontinence due to neurogenic detrusor overactivityMedDRA version: 18.0Level: PTClassification code 10029279Term: Neurogenic bladderSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2014-004641-27-BEZLeuven30
Recruiting
Phase 4
Botox in the treatment of Raynaud's phenomenon in sclerodermasystemic sclerosis (scleroderma).Systemic sclerosis [scleroderma]IRCT20081202001479N7Mashhad University of Medical Sciences30
Active, not recruiting
Phase 1
BB trial; Effect of botox in Piriformis syndromeCTIS2023-504427-61-01Stichting Alrijne Zorggroep36
Completed
Not Applicable
The efficacy of botulinum toxin in the treatment of chronic neck symptoms after whiplash injuriesMusculoskeletal Diseases: Neck painMusculoskeletal DiseasesNeck painISRCTN36437589Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)100